Featured Story
Featured
FDA Proposes New Rule to Standardize Asbestos Testing in Talc-Based Cosmetics
Matthew Davis
4 mins read - December 27, 2024
The U.S. Food and Drug Administration (FDA) has proposed a groundbreaking rule to enhance consumer safety by requiring standardized testing methods for detecting asbestos in talc-containing cosmetic products. This initiative addresses mounting public concern over asbestos contamination in talc-based items, which has been linked to...
News & Data
Johnathan Edwards - November 11, 2024
Arizona Veterans: The Persistent Danger of Asbestos Exposure
Matthew Davis - November 4, 2024
Judge Halts Most J&J Talc Lawsuits In Bankruptcy Settlement Push
Matthew Davis - September 23, 2024
Johnson & Johnson Faces Critical Legal Test in Connecticut
Amna Anees - September 23, 2024
FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
Rachel Sasser - September 20, 2024
J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement
Rachel Sasser - September 18, 2024
$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc
Matthew Davis - September 11, 2024
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
Matthew Davis - September 10, 2024
J&J Raises Talcum Powder Settlement by Another $1.1 Billion
Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.
CONTACT US
Email: support@mesowatch.com
Phone: (866) 402-1000
Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251
Copyright © 2025 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer